Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
3.32
↓ 100% below average
Average (6y)
4018.76
Historical baseline
Range
High:28127.97
Low:0.00
CAGR
-77.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 3.32 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | -100.0% |
| 2018 | 28127.97 | - |